Cargando…
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
AIM: To evaluate the proteinuria-lowering effect of a renin inhibitor (aliskiren), compared to placebo and to an angiotensin-converting enzyme inhibitor (perindopril), in patients with non-diabetic chronic kidney disease. METHODS: A randomised, double-blind, crossover trial was performed in 14 patie...
Autores principales: | Lizakowski, Sławomir, Tylicki, Leszek, Renke, Marcin, Rutkowski, Przemysław, Heleniak, Zbigniew, Sławińska-Morawska, Maja, Aleksandrowicz, Ewa, Łysiak-Szydłowska, Wieslawa, Rutkowski, Bolesław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510412/ https://www.ncbi.nlm.nih.gov/pubmed/23326865 http://dx.doi.org/10.1007/s11255-011-0110-z |
Ejemplares similares
-
Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients
por: Gołębiewska, Justyna E., et al.
Publicado: (2011) -
Direct renin inhibition – a promising strategy for renal protection?
por: Lizakowski, Sławomir, et al.
Publicado: (2013) -
Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
por: Skonieczny, Piotr, et al.
Publicado: (2021) -
Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease
por: Heleniak, Zbigniew, et al.
Publicado: (2016) -
Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up
por: Malyszko, Jolanta, et al.
Publicado: (2012)